Clinical Trials Directory

Trials / Completed

CompletedNCT04950101

Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
304 (actual)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to determine the prevalence of anal high-risk HPV infection and abnormal cytology in HIV uninfected Men who have sex with men (MSM) using PrEP and HIV infected MSM followed-up at the S-kliniek or HRC of the UZ Brussel. 200 participants will be preferably included in the study. The data will be collected using a self-administered questionnaire where socio-demographic characteristics, health-related issues and sexual behavior will be questioned. Also anal canal sampling will be performed for cytological analysis. For the HIV infected MSM, additional information will be extracted from the patient files: CD4+ T-cell count and nadir and duration of combination antiretroviral therapy.

Conditions

Interventions

TypeNameDescription
OTHERanal samplinganal sampling will be performed both in men without HIV and men having HIV in order to see if they have HPV or not

Timeline

Start date
2020-10-20
Primary completion
2023-05-04
Completion
2025-11-30
First posted
2021-07-06
Last updated
2025-12-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04950101. Inclusion in this directory is not an endorsement.

Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Usi (NCT04950101) · Clinical Trials Directory